• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[镁缺乏性皮炎——白三烯水平的变化以及盐酸氮卓斯汀对该皮炎和白三烯B4的影响]

[Magnesium deficiency dermatitis--changes in leukotriene levels and effects of azelastine hydrochloride on the dermatitis and leukotriene B4].

作者信息

Hanada K, Akita N, Hashimoto I

机构信息

Department of Dermatology, Hirosaki University School of Medicine.

出版信息

Nihon Hifuka Gakkai Zasshi. 1990 Jun;100(7):757-60.

PMID:1976840
Abstract

To estimate the pathogenesis of magnesium deficiency dermatitis (MDD) in the hairless rats fed with a hypomagnesic diet, plasma concentrations of leukotrienes (LTB4, LTC4, LTD4) were measured. Inhibitory effect of azelastine hydrochloride (AZ), which is known as an inhibitor of 5-lipoxygenase, on MDD was also evaluated. In the hairless rats with magnesium deficiency condition, plasma level of leukotriene B4 was increased, whereas LTC4 and LTD4 showed no changes. In AZ-administered rats, MDD was depressed with the dose-dependent tendency. However, the decrease of LTB4 level did not follow therapeutic effect of AZ for gross appearance of dermatitis. These results indicated that development of MDD associates with increase of LTB4, but its pathogenetic role still remains unknown, and inhibitory effect of AZ against MDD not based on reduction of LTB4 production.

摘要

为评估喂食低镁饮食的无毛大鼠中镁缺乏性皮炎(MDD)的发病机制,检测了血浆中白三烯(LTB4、LTC4、LTD4)的浓度。还评估了作为5-脂氧合酶抑制剂的盐酸氮卓斯汀(AZ)对MDD的抑制作用。在处于镁缺乏状态的无毛大鼠中,白三烯B4的血浆水平升高,而LTC4和LTD4无变化。在给予AZ的大鼠中,MDD呈剂量依赖性减轻。然而,LTB4水平的降低并未伴随AZ对皮炎总体外观的治疗效果。这些结果表明,MDD的发生与LTB4的增加有关,但其致病作用仍不清楚,且AZ对MDD的抑制作用并非基于LTB4生成的减少。

相似文献

1
[Magnesium deficiency dermatitis--changes in leukotriene levels and effects of azelastine hydrochloride on the dermatitis and leukotriene B4].[镁缺乏性皮炎——白三烯水平的变化以及盐酸氮卓斯汀对该皮炎和白三烯B4的影响]
Nihon Hifuka Gakkai Zasshi. 1990 Jun;100(7):757-60.
2
Inhibitory effect of the leukotriene B4 receptor antagonist against hypomagnesic diet-induced dermatitis in hairless rats.白三烯B4受体拮抗剂对低镁饮食诱导的无毛大鼠皮肤炎的抑制作用。
J Dermatol. 1992 Aug;19(8):456-60. doi: 10.1111/j.1346-8138.1992.tb03261.x.
3
The hypomagnesic rat model: dermatitis-prone hairless rats with mild magnesium depletion fed a diet low in lipids did not develop pruritic dermatitis.
Skin Res Technol. 2005 Feb;11(1):42-6. doi: 10.1111/j.1600-0846.2005.00098.x.
4
The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients.盐酸氮卓斯汀对血液透析患者瘙痒及白三烯B4的影响。
Life Sci. 1995;57(3):207-13. doi: 10.1016/0024-3205(95)00264-7.
5
Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis.急性甲型和乙型肝炎患儿的白三烯(LTC4、D4、E4、B4)血药浓度及外周血白细胞白三烯B4的合成情况。
Turk J Pediatr. 1999 Oct-Dec;41(4):457-65.
6
Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo.白三烯B4在体外和体内均能刺激破骨细胞的骨吸收。
J Bone Miner Res. 1996 Nov;11(11):1619-27. doi: 10.1002/jbmr.5650111105.
7
Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.半胱氨酰白三烯和白三烯B介导大鼠基底动脉对精氨酸加压素的血管收缩作用。
Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1027-33. doi: 10.1111/j.1440-1681.2005.04300.x.
8
5-Lipoxygenase inhibitory and antihistamine activities of linetastine.利奈他定的5-脂氧合酶抑制和抗组胺活性
Arzneimittelforschung. 1996 Nov;46(11):1072-6.
9
Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process.镰状细胞病中的血浆和尿液白三烯:在炎症过程中的可能作用。
Eur J Clin Invest. 1994 Jan;24(1):57-64. doi: 10.1111/j.1365-2362.1994.tb02060.x.
10
Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.新型5-脂氧合酶抑制剂盐酸6-羟基-2(4-氨磺酰苄基氨基)-4,5,7-三甲基苯并噻唑对人嗜酸性粒细胞白三烯C4和B4释放的抑制作用
Arzneimittelforschung. 1995 Sep;45(9):1002-4.